XML 35 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Operating activities:      
Net income (loss) $ 3,325 $ 18,757 $ 5,418
Reconciliation of net income (loss) to cash provided by operating activities:      
Depreciation, depletion, amortization, and accretion 80,985 75,747 94,839
Impairments of long-lived assets 9,578 8,360 15,738
Provision (benefit) for deferred income taxes (9,824) (2,012) (5,757)
Equity-based compensation expense 6,724 9,441 6,288
Provision for doubtful accounts 374 (237) 973
(Gain) loss on sale of property, plant, and equipment (5,776) (4,916) (58,674)
Excess decommissioning/abandoning costs 75,312 40,767 78,382
Other non-cash charges and credits (10,165) (6,527) (6,149)
Changes in operating assets and liabilities, net of assets acquired:      
Accounts receivable 14,139 (31,229) 16,129
Inventories 3,011 (3,749) 2,158
Prepaid expenses and other current assets 12,281 (1,335) 23,447
Trade accounts payable and accrued expenses (16,192) 7,291 (29,984)
Decommissioning liabilities (114,109) (94,419) (101,920)
Other (7) 1,730 2,899
Net cash provided by operating activities 49,656 17,669 43,787
Investing activities:      
Purchases of property, plant, and equipment (101,379) (107,524) (123,604)
Business combinations, net of cash acquired 0 (163,305) (1,500)
Proceeds from sale of property, plant, and equipment 1,794 59,325 188,273
Other investing activities (440) 4,817 (16,330)
Net cash provided by (used in) investing activities (100,025) (206,687) 46,839
Financing activities:      
Proceeds from long-term debt 140,971 88,426 0
Principal payments on long-term debt (120,664) (28,597) 0
Excess tax benefit from equity-based compensation 0 198 1,334
Proceeds from issuance of Compressco Partners' common units, net of underwriters' discount 0 0 50,234
Compressco Partners' offering costs 0 0 (2,747)
Compressco Partners' distributions (4,846) (4,513) (1,159)
Proceeds from sale of common stock and exercise of stock options 2,251 784 3,418
Deferred financing costs (1,978) 0 (347)
Net cash provided by (used in) financing activities 15,734 56,298 50,733
Effect of exchange rate changes on cash (659) 2,356 (2,307)
Increase (decrease) in cash and cash equivalents (35,294) (130,364) 139,052
Cash and cash equivalents at beginning of period 74,048 204,412 65,360
Cash and cash equivalents at end of period 38,754 74,048 204,412
Supplemental cash flow information:      
Interest paid 17,728 18,711 18,145
Taxes paid (refunded) 7,438 8,020 (12,649)
Supplemental disclosure of non-cash investing and financing activities:      
Adjustment of fair value of decommissioning liabilities capitalized to oil and gas properties $ 0 $ 0 $ 1,804